OPN and its splice variants (OPN-SV), mainly osteopontin-a (OPNa), osteopontin-b (OPNb) and osteopontin-c (OPNc), are known to activate diverse signaling pathways that are related to tumor progression features [6,7]. Here, SPP1 is linked to neoplasm.